Baughman, R.P. (2025) “WASOG Clinical Trial Endpoint Task Force: Executive Summary”, Sarcoidosis, Vasculitis and Diffuse Lung Diseases, 42(3), p. 17859. doi:10.36141/svdld.v42i3.17859.